Animal models for studying respiratory syncytial virus infection and its long term effects on lung function

Pediatric Infectious Disease Journal

Volumn 23, Issue 11 SUPPL., 2004, Pages

  Domachowske, Joseph B ^a   Bonville, Cynthia A ^a   Rosenberg, Helene F ^b  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Animal models; Pneumonia virus of mice; Respiratory syncytial virus

Indexed keywords

VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BRONCHIOLITIS; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE SEVERITY; IMMUNITY; LUNG FUNCTION; LUNG PARENCHYMA; MOUSE; NONHUMAN; PNEUMONIA; PNEUMOVIRINAE; PRIORITY JOURNAL; RAT; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; ANIMAL DISEASE; BAGG ALBINO MOUSE; CATTLE; DISEASE MODEL; HOSPITALIZATION; HUMAN; INFLAMMATION; LUNG; PATHOLOGY; PHYSIOLOGY; REVIEW; VIROLOGY;

ANIMALS; CATTLE; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; LUNG; MICE; MICE, INBRED BALB C; PNEUMOVIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX;

EID: 16544369087     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000144672.81955.a4     Document Type: Conference Paper

References (29)

1. Domachowske JB, Rosenberg HF. Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev. 1999;12:298-309.
2. Morris JA, Blount RE, Savage RE. Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med. 1956;92:544-549.
3. Crowe JE, Bui PT, Siber GR, Elkins WR, Chanock RM, Murphy BR. Cold passaged temperature sensitive mutants of human respiratory syncytial virus are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine. 1995;13:847-855.
4. Belshe RB, Richardson LS, Londaon WT, et al. Experimental respiratory syncytial virus infection of four species of primates. J Med Virol. 1977;1:157-162.
5. Kakuk TJ, Soike K, Brideau RJ, et al. A human respiratory syncytial virus (RSV) model of enhanced pulmonary pathology induced with a formalin inactivated RSV vaccine but not a recombinant FG subunit vaccine. J Infect Dis. 1993;167:553-561.
6. Baker JC, Ellis JA, Clark EG. Bovine respiratory syncytial virus. Vet Clin North Am Food Anim Pract. 1997;13:425-454.
7. Ellis JA, Philibert H, West K, Clark E, Martin K, Haines D. Fatal pneumonia in adult dairy cattle associated with active infection with bovine respiratory syncytial virus. Can Vet J. 1996;37:103-105.
8. Larsen LE. Bovine respiratory syncytial virus (BRSV): a review. Acta Vet Scand. 2000;41:1-24.
9. Ellis JA. The immunology of the bovine respiratory disease complex. Vet Clin North Am. 2001;17:535-550.
10. Prince GA, Hemming VG, Horswood RL, Chanock RM. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat. Virus Res. 1985;3:193-206.
11. Prince GA, Horswood RL, Chanock RM. Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats. J Virol. 1985;55:517-520.
12. Prince GA, Hemming VG, Horswood RL, Baron PA, Chanock RM. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J Virol. 1987;61:1851-1854.
13. Prince GA, Mathews A, Curtis SJ, Porter DD. Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model with systemically administered monoclonal antibody (palivizumab) and glucocorticosteroid. J Infect Dis. 2000;182:1326-1330.
14. Prince GA, Jenson AB, Hemming VG, et al. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by intramuscular inoculation of formalin inactivated virus. J Virol. 1986;57:721-728.
15. Collins PL, Chanock RM, Murphy BR. Respiratory syncytial virus. In: Knipe DM, Howley PM, eds. Fields Virology, vol. 1. Philadelphia, PA: Lippincott-Raven Publishers; 2001:1443-1486.
16. + T cells. J Virol. 1992;66:7444-7451.
17. Graham BS, Henderson GS, Tang YW, Lu X, Neuzil KM, Colley DG. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus. J Immunol. 1993;151:2032-2040.
18. Easton AJ, Domachowske JB, Rosenberg HF. Animal pneumoviruses: molecular genetics and pathogenesis of infection. Clin Microbiol Rev. 2004;78:390-412.
19. Domachowske JB, Bonville CA, Dyer KD, Easton AJ, Rosenberg HF. Pulmonary eosinophilia and production of MIP-1a are prominent responses to infection with pneumonia virus of mice. Cell Immunol. 2000;200:98-104.
20. Domachowske JB, Rosenberg HF. Gene expression in epithelial cells in response to pneumovirus infection. Respir Res. 2001;2:225-233.
21. Domachowske JB, Bonville CA, Easton AJ, Rosenberg HF. Differential expression of pro-inflammatory cytokine genes in vivo in response to pathogenic and nonpathogenic pneumovirus infection. J Infect Dis. 2002;186:8-14.
22. Bonville CA, Rosenberg HF, Domachowske JB. Macrophage inflammatory protein-1α and RANTES are present in nasal secretions during ongoing upper respiratory tract infection. Pediatr Allergy Immunol. 1999;10:39-44.
23. Harrison MA, Bonville CA, Rosenberg HF, Domachowske JB. Respiratory syncytial virus induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med. 1999;159:1918-1924.
24. Bonville CA, Mehta P, Krilov L, Rosenberg HF, Domachowske JB. Epithelial cells infected with respiratory syncytial virus are resistant to the anti-inflammatory effects of hydrocortisone. Cell Immunol. 2001; 213:134-140.
25. Domachowske JB, Bonville CA, Gao JL, Murphy PM, Easton AJ, Rosenberg HF. The chemokine macrophage inflammatory protein-1α and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection. J Immunol. 2000;165:2677-2682.
26. Bonville CA, Easton AJ, Rosenberg HF, Domachowske JB. Altered pathogenesis of severe pneumovirus infection in response to combined anti-viral and specific immunomodulatory agents. J Virol. 2003;77: 1237-1244.
27. Bonville CA, Lau VK, deLeon JM, et al. Functional antagonism of the chemokine receptor CCR1 is an effective anti-inflammatory strategy in severe pneumovirus infection in vivo. J Virol. 2004;78:7984-7989.
28. Barends M, de Rond LGH, Dormans J, et al. Respiratory syncytial virus, pneumonia virus of mice, and influenza A virus differently affect respiratory allergy in mice. Clin Exp Allergy. 2004;34:488-496.
29. DeLorme MP, Moss OR. Pulmonary function assessment by whole body plethysmography in restrained versus unrestrained mice. J Pharmacol Toxicol Methods. 2002;47:1-10.